Emerging role of cancer-associated fibroblasts in esophageal squamous cell carcinoma
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2023.155002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Wenqing Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi…. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Cancer-Associated Fibroblasts, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 106 Literaturangaben. Gefördert von: Key Research and Development Projects of Shaanxi Province, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Esophageal carcinoma is the sixth leading cause of cancer death globally and the majority of global cases are esophageal squamous cell carcinoma (ESCC). Difficulty in diagnosis exists as more than 70% of ESCC patients are diagnosed at the intermediate or advanced stage. Cancer-associated fibroblasts (CAFs) have been considered one of the crucial components in the process of tumor growth, promoting communications between cancer cells and the tumor microenvironment (TME). CAFs grow alongside malignancies dynamically and interact with ESCC cells to promote their progression, proliferation, invasion, tumor escape, chemo- and radio-resistance, etc. It is believed that CAFs qualify as a promising direction for treatment. Analyzing CAFs' subtypes and functions will elucidate the involvement of CAFs in ESCC and aid in therapeutics. This review summarizes current information on CAFs in ESCC and focuses on the latest interaction between CAFs and ESCC cancer cell discoveries. The origin of CAFs and their communication with ESCC cells and TME are also demonstrated. On the foundation of a thorough analysis, we highlight the clinical prospects and CAFs-related therapies in ESCC in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an, China.
- Department of Neurosurgery, General Hospital of Northern Theater Command, Shenyang, China. Electronic address: kingsea300809@163.com.
- State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an, China. Electronic address: limingyang1108@sina.com.
- Department of Reproductive Medicine, Xi'an International Medical Center Hospital, Northwest University, Xi'an, China. Electronic address: 361400283@qq.com.
Förderung
- Key Research and Development Projects of Shaanxi Province
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Li, W., Xu, T., Jin, H., Li, M., & Jia, Q. (2024). Emerging role of cancer-associated fibroblasts in esophageal squamous cell carcinoma. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.155002
Vancouver
Li W, Xu T, Jin H, Li M, Jia Q. Emerging role of cancer-associated fibroblasts in esophageal squamous cell carcinoma. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2023.155002
BibTeX
@article{Li2024,
author = {Li, Wenqing and Xu, Tianqi and Jin, Hai and Li, Mingyang and Jia, Qingge},
title = {Emerging role of cancer-associated fibroblasts in esophageal squamous cell carcinoma},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2023.155002}
}
EUVIMED